Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma

NCT02448056 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02448056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02448056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2015
Completion date
May 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, marker, biological